J.P. Morgan Predicts Fall Sell-Off and Highlights Defensive Stocks
J.P. Morgan's Jason Hunter has raised concerns about potential weaknesses in the S&P 500 as the fall season approaches. He notes that current market conditions bear a striking resemblance to those leading up to the tech crash of 1999-2000. Rising Treasury yields and a divergence in AI stock performance are contributing factors to this outlook.
Historically, September has been the worst month for stock performance, with the S&P 500 averaging a negative return of approximately 0.7% to 1% since 1928. Institutional investors often engage in sell-offs at the end of the third quarter to secure gains or adjust their asset allocations. This trend, combined with traders returning from summer vacations to reassess their portfolios, typically leads to a shift towards more defensive investment strategies.
Market Reading & Resources
Sponsor funding complete. Trade on.
J.P. Morgan's technical team has identified several warning signs, including deteriorating market internals and a lack of confidence in the tech and AI sectors. Hunter emphasizes the growing disparity between AI hardware manufacturers and those investing heavily in AI capital expenditures, which he believes mirrors the market behavior observed before the tech bubble burst.
In light of these concerns, J.P. Morgan has recommended five defensive sectors for investors seeking stability amid potential market volatility. These sectors are expected to provide growth opportunities while being less susceptible to the fluctuations seen in technology and AI/data center stocks.
Among the recommended stocks is GE Vernova, which operates in the electric power sector and has been identified as a top pick for its potential in electrification infrastructure. The firm has set a price target of $1,330 for GE Vernova shares. Citigroup is also highlighted, with a price target of $149, offering a 1.74% dividend yield. Additionally, Walmart, despite recent challenges, remains a solid choice with a 0.83% dividend yield and a target price of $125.
Bristol Myers Squibb, a biopharmaceutical company, is noted for its reliable 3.83% dividend and a revised target price of $73. Lastly, Caterpillar, which has performed exceptionally well this year, is recommended with a target price of $1,165 and a 0.70% dividend yield. These stocks are positioned as safer investments for growth and income during uncertain market conditions.




